Recent advances in the therapy of castration-resistant prostate cancer: the price of progress.
about
Economic evaluation of therapeutic cancer vaccines and immunotherapy: a systematic review.A novel personalized vaccine approach in combination with targeted therapy in advanced renal cell carcinoma.Cost-effectiveness of denosumab as a bone protective agent for patients with castration resistant prostate cancer.A new age for vaccine therapy in renal cell carcinoma.Sipuleucel-T (Provenge(®))-Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention.
P2860
Recent advances in the therapy of castration-resistant prostate cancer: the price of progress.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Recent advances in the therapy ...... cancer: the price of progress.
@ast
Recent advances in the therapy ...... cancer: the price of progress.
@en
type
label
Recent advances in the therapy ...... cancer: the price of progress.
@ast
Recent advances in the therapy ...... cancer: the price of progress.
@en
prefLabel
Recent advances in the therapy ...... cancer: the price of progress.
@ast
Recent advances in the therapy ...... cancer: the price of progress.
@en
P2093
P2860
P1433
P1476
Recent advances in the therapy ...... cancer: the price of progress.
@en
P2093
Courtney Carmichael
David Y Josephson
Dhwanishiva Vasani
Oliver Sartor
Sumanta Kumar Pal
P2860
P304
P356
10.1016/J.MATURITAS.2011.07.018
P577
2011-08-09T00:00:00Z